Revolution Medicines (RVMD) Other Non Operating Income (2024 - 2026)

Revolution Medicines' Other Non Operating Income history runs 3 years deep, the most recent figure standing at $117000.0 for Q1 2026.

• On a quarterly basis, Other Non Operating Income rose 1270.0% year-over-year to $117000.0 in Q1 2026; TTM through Mar 2026 was $58.3 million, a 2410.67% increase from a year earlier, with the FY2025 full-year figure at $58.1 million, changed N/A from the prior year.
• Other Non Operating Income declined to $117000.0 in Q1 2026 per RVMD's latest filing, from $58.1 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $58.1 million in Q4 2025 and bottomed at -$2.8 million in Q1 2024.
• The 3-year median for Other Non Operating Income is $66500.0 (2024), against an average of $9.3 million.
• Across the five-year window, Other Non Operating Income soared 99.64% in 2025 and soared 1270.0% in 2026, its largest moves.
• Year by year, Other Non Operating Income stood at $282000.0 in 2024, then soared by 20518.79% to $58.1 million in 2025, then sank by 99.8% to $117000.0 in 2026.
• Per Business Quant, the three latest RVMD Other Non Operating Income figures stand at $117000.0 (Q1 2026), $58.1 million (Q4 2025), and -$10000.0 (Q1 2025).